Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: Implications for the diagnosis of combined obstructive and restrictive lung disease

Mayo Clinic Proceedings

Volumn 82, Issue 1, 2007, Pages 48-54

  Aduen, Javier F ^a   Zisman, David A ^b   Mobin, Syed I ^a   Venegas, Carla ^a   Alvarez, Francisco ^a   Biewend, Michelle ^a   Jolles, Howard I ^a   Keller, Cesar A ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; PHYSICAL ACTIVITY; RESIDUAL VOLUME; RESPIRATORY AIRFLOW; REST; RETROSPECTIVE STUDY; SMOKING; SYMPTOMATOLOGY; TOTAL LUNG CAPACITY;

EID: 33846032315     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.1.48     Document Type: Article

References (42)

1. Crapo RO, Forster RE II. Carbon monoxide diffusing capacity. Clin Chest Med. 1989;10:187-198.
2. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:S77-S121.
3. Chetta A, Marangio E, Olivieri D. Pulmonary function testing in interstitial lung diseases. Respiration. 2004;71:209-213.
4. Al-Aslikar F, Mehra R, Mazzone PJ. Interpreting pulmonary function tests: recognize the pattern, and the diagnosis will follow. Cleve Clin J Med. 2003;70:866, 868, 871-873.
5. Crapo RO, Jensen RL, Wanger JS. Single-breath carbon monoxide diffusing capacity. Clin Chest Med. 2001;22:637-649.
6. LCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume. Respir Med. 2000;94:28-37.
7. Ansari A, Collier J, Mohsenifar Z. Isolated reduction in single-breath diffusion capacity in young, healthy, asymptomatic women. Am J Med Sci. 1995;310:226-228.
8. Steen VD, Graham G, Conte C, Owens G, Medsger TA Jr. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum. 1992;35:765-770.
9. Doherty MJ, Pearson MG, O'Grady EA, Pellegrini V, Calverley PM. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax. 1997;52:998-1002.
10. Colp C, Park SS, Williams MH Jr. Emphysema with little airway obstruction. Am Rev Respir Dis. 1970;101:615-619.
11. Klein JS, Gamsu G, Webb WR, Golden JA, Muller NL. High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. Radiology. 1992;182:817-821.
12. Wiggins J, Strickland B, Turner-Warwick M. Combined Cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med. 1990:84:365-369.
13. Wolkowicz J, Sturgeon J, Rawji M, Chan CK. Bleomycin-induced pulmonary function abnormalities. Chest. 1992;101:97-101.
14. Mukerjee D, St George D, Knight C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford). 2004 Apr;43:461-466. Epub 2004 Jan 6.
15. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol. 2003;41:1028-1035.
16. Ewert R, Mutze S, Schachschal G, Lochs H, Plauth M. High prevalence of pulmonary diffusion abnormalities without interstitial changes in long-term survivors of liver transplantation. Transpl Int. 1999;12:222-228.
17. Mori H, Okubo M, Okamura M, et al. Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus. Intern Med. 1992;31:189-193.
18. Brussel T, Matthay MA, Chernow B. Pulmonary manifestations of endocrine and metabolic disorders. Clin Chest Med. 1989;10:645-653.
19. Forman JW, Ayers LN, Miller WC. Pulmonary diffusing capacity in chronic renal failure. Br J Dis Chest. 1981;75:81-87.
20. Garcia JG, Griffith DE, Williams JS, Blevins WJ, Kronenberg RS. Reduced diffusing capacity as an isolated finding in asbestos- and silica-exposed workers. Chest. 1990;98:105-111.
21. Mohsenifar Z, Collier J, Belman MJ, Koerner SK. Isolated reduction in single-breath diffusing capacity in the evaluation of exertional dyspnea. Chest. 1992;101:965-969.
22. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144:1202-1218.
23. Miller A, Thornton JC, Warshaw R, Bernstein J, Selikoff IJ, Teirstein AS. Mean and instantaneous expiratory flows, FVC and FEV1: prediction equations from a probability sample of Michigan, a large industrial state. Bull Eur Physiopathol Respir. 1986;22:589-597.
24. American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique. Am Rev Respir Dis. 1987;136:1299-1307.
25. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique: 1995 update. Am J Respir Crit Care Med. 1995;152:2185-2198.
26. Miller A, Thornton JC, Warshaw R, Anderson H, Teirstein AS, Selikoff IJ. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state: predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis. 1983;127:270-277.
27. Gurney JW, Jones KK, Robbins RA, et al. Regional distribution of emphysema: correlation of high-resolution CT with pulmonary function tests in unselected smokers. Radiology. 1992;183:457-463.
28. Kazerooni EA, Martinez FJ, Flint A, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol. 1997;169:977-983.
29. Chan KL, Currie PJ, Seward JB, Hagler DJ, Mair DD, Tajik AJ. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol. 1987;9:549-554.
30. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:258-266.
31. Yernault JC, de Jonghe M, de Coster A, Englert M. Pulmonary mechanics in diffuse fibrosing alveolitis. Bull Physiopathol Respir (Nancy). 1975;11:231-244.
32. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-968.
33. Cottin V, Nunes H, Brillet PY, et al, Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26:586-593.
34. Niewoehner DE, Hoidal JR. Lung fibrosis and emphysema: divergent responses to a common injury? Science. 1982;217:359-360.
35. Hoidal JR, Niewoehner DE. The role of tissue repair and leukocytes in the pathogenesis of emphysema. Chest. 1983;83(suppl):58S-59S.
36. Hoyle GW, Li J, Finkelstein JB, et al. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol. 1999;154:1763-1775.
37. Flaherty KR, Hunninghake GG. Smoking: an injury with many lung manifestations. Am J Respir Crit Care Med. 2005;172:1070-1071.
38. Baumgartner KB, Samet JM, Coultas DB, et al. Collaborating Centers. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Am J Epidemiol. 2000;152:307-315.
39. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256-1276.
40. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [published correction appears in Eur Respir J. 2006;27:242].
41. Eur Respir J. 2004;23:932-946.
42. 1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest. 2006;130:200-206.